List of works by Raed Alroughani

Adherence to first-line disease-modifying therapy for multiple sclerosis in kuwait

scientific article published on January 2012

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis

scientific article published on 01 November 2018

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

scientific article published on 01 January 2019

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder

scientific article published on 25 November 2019

Clinical characteristics of multiple sclerosis in Kuwait: data from the new MS registry of Amiri Hospital.

scientific article

Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom ⬇️

journal article from 'PharmacoEconomics' published in 2022

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

scientific article published on 13 January 2019

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

scientific article published on April 2015

Consensus guidelines for the diagnosis and treatment of multiple sclerosis

scientific article published on 22 April 2013

Contribution of different relapse phenotypes to disability in multiple sclerosis.

scientific article published on 7 April 2016

Defining reliable disability outcomes in multiple sclerosis.

scientific article published on 10 September 2015

Defining secondary progressive multiple sclerosis

scientific article published on 7 July 2016

Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

scientific article published on 15 June 2020

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

scientific article published on 13 June 2016

Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

scientific article published on 28 December 2020

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies

scientific article published on 25 November 2019

Endovascular treatment of chronic cerebrospinal venous insufficiency in multiple sclerosis: a retrospective study.

scientific article published on 4 February 2013

Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity

scientific article published on 28 February 2020

Family planning is the second most relevant factor for treatment decisions after disease activity - Yes

scientific article published on 21 February 2020

Fingolimod after natalizumab and the risk of short-term relapse

scientific article published on 07 March 2014

Fingolimod-associated amenorrhea: a report of three cases

scientific article

Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries

scientific article published on 17 December 2013

High discontinuation rate of natalizumab in JC virus seropositive patients due to significant anxiety and safety feelings

scientific article published on 11 March 2014

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

scientific article published on 3 November 2016

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

scientific article published on 28 September 2016

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

scientific article published on 03 January 2019

Increasing prevalence and incidence rates of multiple sclerosis in Kuwait.

scientific article published on 11 September 2013

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

scientific article published on April 2017

Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod

scientific article published on 22 November 2017

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

scientific article published on 5 June 2015

Migraine misdiagnosis as a sinusitis, a delay that can last for many years

scientific article

Multiple sclerosis reactivation postfingolimod cessation: is it IRIS?

scientific article

Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring

scientific article

Neuromyelitis optica spectrum disorders in the Arabian Gulf: challenges and growing experience

scientific article published on 10 January 2020

Non-convulsive status epilepticus; the rate of occurrence in a general hospital

scientific article

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

scientific article

Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score

scientific article published on 08 July 2020

Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria

scientific article

Predictors of disability worsening in clinically isolated syndrome.

scientific article published on 27 March 2015

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.

scientific article published on 18 December 2016

Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait

scientific article published on 22 January 2014

Prognostic indicators in pediatric clinically isolated syndrome

scientific article published on 25 April 2017

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.

scientific article published on 24 November 2016

Recurrent Wernicke's Encephalopathy in a 16-Year-Old Girl with Atypical Clinical and Radiological Features

scientific article published on 10 February 2014

Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype

scientific article published on 31 October 2019

Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)]

scientific article published on 24 February 2018

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study

scientific article published on 01 July 2019

Risk of relapse phenotype recurrence in multiple sclerosis.

scientific article

Risk of secondary progressive multiple sclerosis: A longitudinal study

scientific article published on 09 August 2019

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

scientific article published on 20 October 2014

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

scientific article published on 18 October 2013

Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis

scientific article published on 20 September 2018

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.

scientific article published on 17 January 2015

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

scientific article published on 21 July 2015

The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective

scientific article published on 16 September 2020

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

scientific article published in September 2017

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

scientific article published on 10 February 2017

Updated Results of the COVID-19 in MS Global Data Sharing Initiative

scientific article published in 2022

Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait.

scientific article

Use of natalizumab in patients with active relapsing-remitting multiple sclerosis in Kuwait.

scientific article published on 19 June 2013

Paulina is supported by:

About Paulina

Help